Hepatocyte Growth-promoting Factor for Injection - Résultats de recherche

Australie - anglais - Department of Health (Therapeutic Goods Administration)

hospira levetiracetam concentrate for iv infusion levetiracetam 500 mg/5 ml concentrate for infusion vial

pfizer australia pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: nitrogen; sodium acetate trihydrate; sodium chloride; glacial acetic acid; water for injections - hospira? levetiracetam concentrate for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible. levetiracetam is indicated for: use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation; monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy and add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

evoltra clofarabine 20 mg/20 ml concentrated solution for infusion vial

sanofi-aventis australia pty ltd - clofarabine, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium chloride - treatment of acute lymphocytic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens. this use is based on the induction of complete responses.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

levetiracetam sandoz levetiracetam 500 mg /5 ml concentrate solution for iv infusion vial

sandoz pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sodium acetate trihydrate; glacial acetic acid - levetiracetam sandoz concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.,levetiracetam sandoz concentrate solution for iv infusion is indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with jme. ? add on therapy in the treatment of pgtc seizures in adults and children from 4 years of age with ige.